Eton Pharmaceutcials, Inc. Common Stock (ETON) is a publicly traded Healthcare sector company. As of September 22, 2026, ETON trades at $57.52 with a market cap of $1.59B and a P/E ratio of 118.82. ETON moved +3.99% today. Year to date, ETON is +227.09%; over the trailing twelve months it is +201.58%. Its 52-week range spans $11.09 to $66.37. Analyst consensus is strong buy with an average price target of $61.50. Rallies surfaces ETON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ETON insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $57.52 |
| Market Cap | $1.59B |
| P/E Ratio | 118.82 |
| EPS | $0.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $66.37 |
| 52-Week Low | $11.09 |
| Volume | 950 |
| Avg Volume | 0 |
| Revenue (TTM) | $105.59M |
| Net Income | $12.69M |
| Gross Margin | 57.87% |
4 analysts cover ETON: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $61.50.